Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review by Meyer Jonathan M. MD, Chepke Craig MD, Bera Rimal B. MD, Pérez-Rodríguez M. Mercedes MD, PhD, Lundt Leslie MD, Franey Ericha G. PhD, Dhanda Rahul PhD, MA, Benning Betsy MBA, Bron Morgan PharmD, MS, Yonan Chuck PharmD

Get full text